Loading...
935106861
info@markelab.com
Precio
375€ (100 µg)
Tomaralimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TLR2/CD282, Tomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).
Biosimilars
Human, Mouse
Monoclonal
Human
TLR2/CD282
Human, Mouse
IgG4 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1449294-76-1
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más